← Back to Clinical Trials
Recruiting Phase 1 NCT05018845
Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for CKD
Trial Parameters
Condition Chronic Kidney Diseases
Sponsor The Foundation for Orthopaedics and Regenerative Medicine
Study Type INTERVENTIONAL
Phase Phase 1
Enrollment 20
Sex ALL
Min Age N/A
Max Age N/A
Start Date 2021-11-06
Completion 2025-11
Interventions
AlloRx
Brief Summary
This trial will study the safety and efficacy of intravenous infusion of cultured allogeneic adult umbilical cord derived mesenchymal stem cells for the treatment of Chronic Kidney Disease.
Eligibility Criteria
Inclusion Criteria: * Diagnosis of Chronic Kidney Disease * Understanding and willingness to sign a written informed consent document Exclusion Criteria: * Active infection * Active cancer * Chronic multisystem organ failure * Pregnancy * Clinically significant abnormalities on pre-treatment laboratory evaluation * Medical condition that would (based on the opinion of the investigator) compromise patient's safety. * Continued drug abuse * Pre-menopausal women not using contraception * Previous organ transplant * Hypersensitivity to sulfur
Related Trials
NCT06322056
Exploring Approaches With Lower Targets of Blood Pressure and Lipid for Improving Renal Outcome in A
View Trial →
NCT04522622
Treatment of Adynamic Bone Disorder With Parathyroid Hormone in Chronic Kidney Disease
View Trial →
NCT06738394
Enhancing Physical Function in Older Adults With Chronic Kidney Disease
View Trial →